Article
Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone…
eLife · 2024 · Ling Zhou, author Chengyang Ni, author Ruixue Liao, author Xiaoqin Tang, author Taian Yi, author Mei Ran, author Miao Huang, author Rui Liao, author Xiaogang Zhou, author Dalian Qin, author Long Wang, author Feihong Huang, author Xiang Xie, author Ying Wan, author Jiesi Luo, author ([email protected]) Yiwei Wang, author ([email protected]) Jianming Wu, author ([email protected]) Yongliang Yang, editor Jonathan A Cooper, senior_editor
Key facts
| Title | Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia |
|---|---|
| First author | Ling Zhou, author Chengyang Ni, author Ruixue Liao, author Xiaoqin Tang, author Taian Yi, author Mei Ran, author Miao Huang, author Rui Liao, author Xiaogang Zhou, author Dalian Qin, author Long Wang, author Feihong Huang, author Xiang Xie, author Ying Wan, author Jiesi Luo, author ([email protected]) Yiwei Wang, author ([email protected]) Jianming Wu, author ([email protected]) Yongliang Yang, editor Jonathan A Cooper, senior_editor |
| Journal | eLife |
| Published | Apr 4, 2024 |
| DOI | 10.7554/eLife.94765.3 |
| Devices mentioned | 212845, K041074, K062087, K141468, K832428, K910800, K952252, K960557 |
| Product codes mentioned | GHR, GKZ, JPK, OYE, LXG, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1